Combination of Pembrolizumab With TGR-1202 in Patients With Relapsed/Refractory CLL and B-cell NHL
Clinical trial NCT03283137 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03283137
- Sponsor
- University of Chicago
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-23
- Primary completion
- 2027-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.